Viewing Study NCT02446795


Ignite Creation Date: 2025-12-24 @ 1:38 PM
Ignite Modification Date: 2026-02-05 @ 12:41 PM
Study NCT ID: NCT02446795
Status: UNKNOWN
Last Update Posted: 2017-01-18
First Post: 2015-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Sponsor: Consorzio Oncotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module